Top Story

Researchers compare CCP profile of patients with JIA vs RA

April 26, 2017

Among patients with rheumatoid arthritis and patients with a polyarticular subtype of juvenile idiopathic arthritis, researchers at University College London compared profiles of antibodies to cyclic citrullinated peptide profiles.

“[This] study has demonstrated the novel finding that adolescent [rheumatoid factor-positive polyarticular juvenile idiopathic arthritis] pJIA (RF+ve) patients are distinct in their anti-[cyclic citrullinated protein] CCP antibody phenotype from other JIA clinical patterns and age/sex matched healthy controls; but are comparable to adult RF-positive patients in their levels of IgG anti-CCP and shared expression of the same inherently autoreactive 9G4 idiotype,” Yiannis Ioannou, PhD, at the Arthritis Research UK Centre for Adolescent Rheumatology at University College London, and colleagues wrote. “However, it was found that the adult group had significantly higher levels of IgA and IgM anti-CCPs than the adolescent group, suggesting that further investigation is needed to fully elucidate the extent to which these two conditions may be seen as one.”

In the Journals

Younger adults experiencing more ischemic strokes, CV risk factors

April 26, 2017
Even with the decrease of stroke mortality rates in older adults, hospitalization rates for ischemic stroke and traditional stroke risk factors are on the rise in young…

Survey: Employees want better vision coverage, education

April 26, 2017
Companies can help increase employee satisfaction by simply offering vision coverage, according to research from Transitions Optical examining the significance of vision…
In the Journals PlusPerspective

Radiotherapy boost may reduce ipsilateral breast tumor recurrence in women with DCIS

April 26, 2017
Radiotherapy boost after whole-breast radiotherapy led to lower rates of ipsilateral breast tumor recurrence in patients with ductal carcinoma in situ, according to…
FDA News

Glenmark initiates clinical investigation of proposed biosimilar for Xolair

April 26, 2017
Glenmark Pharmaceuticals announced that the FDA has cleared its investigational new drug application to initiate a first-in-human trial of GBR 310, a proposed…
More News Headlines »

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Original ResearchOpen Access

Validating Health Literacy and Numeracy Measures in Minority Groups

HLRP: Health Literacy Research and Practice, Spring 2017, Volume 1 Issue 2
Validation studies of existing health literacy or numeracy tools among racial/ethnic minorities are limited. This study…
More »
International Liver Congress

International Liver Congress

Meeting News

VIDEO: Viral decline, drug level measured with fine-needle aspiration

April 22, 2017
More »